Thromb Haemost 1978; 39(02): 546-548
DOI: 10.1055/s-0038-1646724
Letters to the Editor
Schattauer GmbH Stuttgart

Activation of Platelet Coagulant Activities by Formalin

Sharron L Pfueller
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
,
Pari Hosseinzadeh
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
,
Barry G Firkin
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
,
Margaret A Howard
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
,
Lyne E Hendrix
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
,
Pamela Booth
Department of Medicine, Monash University Medical School, Alfred Hospital, Prahran Vic. 3181, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

 
  • References

  • 1 Allain JP, Cooper HA, Wagner RH, Brinkhous KM. 1975; Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand’s factor and platelet aggregating factor. Journal of Laboratory and Clinical Medicine 85: 318
  • 2 Brown RS, Niewiarowski S, Stewart GJ, Millman M. 1977; A double-isotope study on incorporation of platelets and red cells into fibrin. Journal of Laboratory and Clinical Medicine 90: 130
  • 3 COHEN L, Glaser T, Seligsohn U. 1975; Effects of ADP and ATP on bovine fibrinogen - and ristocetin-induced platelet aggregation in Glanzmann’s thrombasthenia. British Journal of Haematology 31: 343
  • 4 Grant RA, Zucker MB, Mcpherson J. 1976; ADP-induced inhibition of von Willebrand factor-mediated platelet agglutination. American Journal of Physiology 230: 1406
  • 5 Holmsen H, Setowsky Dangelmaier CA. 1977; Adenine nucleotide metabolism of blood platelets. X. Formaldehyde stops centrifugation-induced secretion after A23187-stimulation and causes breakdown of metabolic ADP. Biochemica et biophysica acta 497: 46
  • 6 Howard MA, Firkin BG. 1971; Ristocetin - a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362
  • 7 Kirby EP, Mills DCB. 1975; The interaction of bovine factor VIII with human platelets. Journal of Clinical Investigation 56: 491
  • 8 Macfarlane DE, Stibbe J, Kirby EP, Zucker MB, Grant RA, Mcpherson J. 1975; A method for assaying von Willebrand factor (Ristocetin cofactor). Thrombosis et Diathesis Haemorrhagica 34: 306
  • 9 Nachman RL, Jaffe EA, Weksler BB. 1977; Immunoinhibition of ristocetin-induced platelet aggregation. Journal of Clinical Investigation 59: 143
  • 10 Pfueller SL, Jenkins CSP, LüSCHER EFL. 1977; A comparative study of the effect of modification of the surface of human platelets on the receptors for aggregated immunoglobulins and for ristocetin-von Willebrand factor. Biochimica et biophysica acta 465: 614
  • 11 Pitney WR, Dacie JV. 1953; A simple method of studying the generation of thrombin in recalcified plasma. Journal of Clinical Pathology 6: 9
  • 12 Quick AJ. 1951. The physiology and pathology of hemostasis. Lea and Febiger; Philadelphia:
  • 13 Spaet TH, Cintron J. 1965; Studies on platelet factor 3 availability. British Journal of Haematology 11: 269
  • 14 Weiss HJ, Rogers J, Brand H. 1973; 52: 2697
  • 15 Wu KK, Hoak JC. 1974; A new method for quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet II: 924